Speakers:
– Alan Hennessy, Discovery & Exploratory Team Lead, GARDP (Switzerland)
– Mo Yin, Consultant, ADVANCE-ID, National University Hospital (Singapore)
– Herbert Wetli, Head of Pharmaceutical Development, GARDP (Switzerland)

Moderator:
Rosemary Dorrington, Professor of Microbiology, Rhodes University (South Africa)

A key measure to mitigate antimicrobial resistance is to develop new antibiotics but how is this done? Join us for an introduction to the stages of this process from discovery to clinical trials and pharmaceutical development. A must-watch for students and clinicians or anyone interested in learning more about what is being done to control the AMR crisis.

Presentation 1: An Overview of Modern Antibacterial Discovery (Alan Hennessy)
Presentation 2: An overview of antibiotic clinical trials (Mo Yin)
Presentation 3: Chemistry, Manufacturing and Controls (CMC) in Drug Development (Herbert Wetli)

More information can be found on the REVIVE website: https://revive.gardp.org/an-introduction-to-antibiotic-rd/
If you have questions or comments, please let us know: revive@gardp.org